5/17
09:11 am
abus
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value [Yahoo! Finance]
Low
Report
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value [Yahoo! Finance]
5/17
09:00 am
abus
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
Low
Report
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
5/7
07:30 am
abus
Arbutus to Participate in Two Upcoming Investor Conferences
Low
Report
Arbutus to Participate in Two Upcoming Investor Conferences
5/3
11:34 am
abus
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
09:57 am
abus
Arbutus Biopharma Co. (NASDAQ: ABUS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Low
Report
Arbutus Biopharma Co. (NASDAQ: ABUS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
5/3
07:00 am
abus
Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Medium
Report
Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
5/2
07:45 am
abus
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]
5/2
07:44 am
abus
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024 [Yahoo! Finance]
Low
Report
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024 [Yahoo! Finance]
5/2/2024
07:30 am
abus
arbutus biopharma corporation
IN-LINE
Report
-0.4%
arbutus biopharma corporation
11/7/2023
07:30 am
abus
arbutus biopharma corporation
IN-LINE
Report
-2.1%
arbutus biopharma corporation
8/3/2023
07:30 am
abus
arbutus biopharma corporation
BEAT
Report
-0.5%
arbutus biopharma corporation
5/17
09:03 am
abus
Form SC 13D/A Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP
Low
Report
Form SC 13D/A Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP
5/9
08:01 am
abus
Form SC 13D Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP
Low
Report
Form SC 13D Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP
5/2
04:33 pm
abus
Form 10-Q Arbutus Biopharma Corp For: Mar 31
Medium
Report
Form 10-Q Arbutus Biopharma Corp For: Mar 31
5/2
07:31 am
abus
Form 8-K Arbutus Biopharma Corp For: May 02
Low
Report
Form 8-K Arbutus Biopharma Corp For: May 02
5/2
07:26 am
abus
Form 8-K Arbutus Biopharma Corp For: May 01
Medium
Report
Form 8-K Arbutus Biopharma Corp For: May 01
4/10
04:07 pm
abus
Form DEFA14A Arbutus Biopharma Corp
Low
Report
Form DEFA14A Arbutus Biopharma Corp
4/10
04:06 pm
abus
Form DEF 14A Arbutus Biopharma Corp For: May 22
Low
Report
Form DEF 14A Arbutus Biopharma Corp For: May 22
4/4
08:31 am
abus
Form 8-K Arbutus Biopharma Corp For: Apr 04
Low
Report
Form 8-K Arbutus Biopharma Corp For: Apr 04
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register